Reavis Bell
Primary Care · Clovis, NMNPI 1427713536
Payments from drug & device makers
What this record shows
Axonics, Inc. accounts for 76.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $1,251 and has fallen 98.2% since, to $22 in 2025.
Across 22 payments — averaging $68.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Ultragenyx Pharmaceutical Inc.$64
- Mylan Specialty L.p.$56
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$50
- Xeris Pharmaceuticals, Inc.$38
- AbbVie$32
- plus $110 from 6 others
What the payments were for
- Travel & lodging$80053%
- Food & beverage$69747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 7 | $1,147 |
| Ultragenyx Pharmaceutical Inc. | 1 | $64 |
| Mylan Specialty L.p. | 3 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| AbbVie | 2 | $32 |
| BD | 1 | $22 |
| Amgen | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$973
How this compares
$1,497 in reported general payments places this provider in the 85th percentile of 58 primary care providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $16,735 |
| Fluticasone Propionate | 75 | $824 |
| Cefdinir | 35 | $491 |
| Levothyroxine Sodium | 58 | $486 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $405 |
| Ondansetron OdtOndansetron | 18 | $392 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $387 |
| Sertraline Hcl | 29 | $285 |
| Lisinopril | 26 | $270 |
| Pantoprazole Sodium | 40 | $268 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $263 |
| Amlodipine Besylate | 39 | $261 |
| Gabapentin | 31 | $261 |
| Doxycycline Monohydrate | 29 | $260 |
| Metoprolol Succinate | 16 | $237 |
Paid to pharmacies, not to this prescriber.
Other primary care in Clovis
- Beverly GriswoldClovis$73
- Bianca MezaAlbuquerque$59K
- Melissa PinoAlbuquerque$4K
- Jacqueline MessierAlbuquerque$3K
- Christine MayesAlbuquerque$2K
- Rachel VanwetteringAlbuquerque$2K
- Catherine JamesAlbuquerque$2K
- Christine VargaSanta Fe$2K
- Koryn MichaudAlbuquerque$1K
- Anna NanceSocorro$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.